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Abstract Nitric oxide is known as an inhibitor of soybean 
lipoxygenase-1. Investigating the interaction of a mammalian 15- 
lipoxygenase with nitric oxide, we found that this enzyme is also 
inhibited reversibly when incubated with nitric oxide for a short 
time period (5 s) under anaerobic conditions. This inhibition may 
be due to the formation of a dissociable lipoxygenase-nitric oxide 
complex. With longer incubation periods the ferrous lipoxygen- 
ase is oxidised to a ferric form. This oxidation renders the 
enzyme more susceptible to peroxide activation, causing a time- 
dependent shortening of the kinetic lag phase. 
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I. Introduction 
Nitric oxide (NO) exhibits a variety of biologically relevant 
activities, such as smooth muscle relaxation, inhibit ion of cell 
proliferation, inhibit ion of platelet aggregation and down reg- 
ulation of the expression of adhesion molecules [1-5]. In vitro 
studies on the interaction of NO with metal loproteins indi- 
cated its capabil ity of complexing enzyme-bound ferrous ions 
[6,7]. The soybean lipoxygenase which contains 1 gatom non- 
heme iron per mol enzyme is reversibly inhibited by nitric 
oxide [6,8]. EPR studies indicated that this inhibit ion may 
be due to the formation of a ferrous l ipoxygenase-NO com- 
plex [8,9]. For  mammal ian lipoxygenases which also contain 
1 gatom iron/enzyme molecule, no experimental data are 
available on their interaction with NO. In the present study 
we investigated the reaction of the purified 15-1ipoxygenase of 
rabbit  reticulocytes with nitric oxide and found that NO is 
capable of oxidising the ferrous enzyme to a pre-activated 
ferric form. 
2. Material and methods 
bised by gently blowing argon over it for several hours on ice. 
More vigorous methods uch as securation or bubbling argon through 
the solution inactivated the enzyme. 2-5 ~1 of this enzyme solution 
were mixed with 5 100 ~tl of the NO stock under argon atmosphere 
and incubated for various time periods. Then 0.90-1.0 ml of aerobic 
phosphate buffer containing 250 I.tM linoleic acid and 0.2% sodium 
cholate was added and the lipoxygenase activity was measured spec- 
trophotometrically recording the increase in absorbance at 235 nm. 
2.2. Electron paramagnetic resonance spectroscopy (EPR) 
EPR spectra were recorded with an ESR 300 spectrometer (ZWG, 
Berlin, Germany) at 4 K. For detection of the lipoxygenase-NO com- 
plex the lyophilised enzyme was flushed extensively with oxygen-free 
argon gas. Then NO gas was blown into the tube, the sample was 
quickly cooled to 4 K and EPR spectra were taken immediately after- 
wards. The control sample was handled identically with the exception 
that the enzyme was flushed with argon gas instead of NO. For long- 
term incubations 1ml of the partially anaerobic enzyme solution (10 
mg/ml) was mixed under an argon atmosphere with 2 ml of the NO 
stock solution, yielding a final NO concentration of about 1 mM. 
After 15 min of incubation the sample was frozen in liquid nitrogen, 
lyophilised and the EPR spectrum was taken at 4 K. In the control 
experiment the enzyme was treated in the same way with the exception 
that a saturated argon solution was added instead of the NO stock. 
2.3. X-ray absorption near edge spectroscopy (XANES) 
The enzyme samples for X-ray absorption spectroscopy were pre- 
pared in the same way as described for the EPR studies. The lyophi- 
lised enzyme was packed into a measuring cell (1 mm thickness) con- 
taining a Kapton-eovered measuring window. X-ray absorption 
measurements were carried out with the EMBL (European Molecular 
Biology Laboratory) X-ray absorption spectrometer [11] at HASY- 
LAB (c/o Deutsches Elektron Synchrotron, Hamburg). A Si(III) dou- 
ble crystal monochromator with an energy resolution of 1.9 eV at 
7250 eV resulting in a AEIE= 2.6 × 10 -4 was used. The second mono- 
chromator crystal was detuned to 50% in order to reject harmonics of 
higher order. The monochromator angle was converted to an absolute 
energy scale by applying a calibration technique [11] resulting in an 
accuracy better than 0.2 eV. The X-ray absorption spectra were re- 
corded by monitoring the X-ray fluorescence with a 13-element ger- 
manium solid-state detector. Series of 22-55 spectra were taken for 
each sample at 20 K in the range of 6900-7900 eV with steps of 0.3 eV 
in the near edge region. No evident damage of the protein sample 
occurred uring exposure to the X-ray beam 
2.1. Chemicals and preparations 
Linoleic acid and sodium cholate were obtained from Serva (Hei- 
delberg, Germany), NO gas from Linde (Munich, Germany). The 
rabbit reticulocyte 15-1ipoxygenase was purified to electrophoretic 
homogeneity as described in [10]. The nitric oxide stock solution 
was prepared by repeated evacuation of 2 ml of 0.1 M phosphate 
buffer (pH 7.4) and re-equilibration with oxygen-free helium gas. 
Afterwards nitric oxide was bubbled through this solution for 20 
min. Oxygraphic measurements indicated that the NO concentration 
of this solution varied between 1.5 and 3.0 mM in various sets of 
experiments. The solution of 15-1ipoxygenase was partially anaero- 
*Corresponding author. Fax: (49) (30) 28468 600. 
3. Results 
3.1. Kinetic studies 
Lipoxygenases require small amounts of hydroperoxide for 
maximal enzymatic activity [12,13]. When hydroperoxide de- 
pleted substrates are used for the rabbit  15-1ipoxygenase a 
kinetic lag period is observed [14]. We detected a kinetic lag 
period when the enzyme was pre-incubated for 5 s with nitric 
oxide under anaerobic ondit ions (Fig. 1). The maximal rates 
(inset) of linoleic acid oxygenation were somewhat lower with 
the NO-treated samples as compared with the untreated en- 
0014-5793/96/$12.00 © 1996 Federation of European Biochemical Societies. All rights reserved. 
PH S00 1 4 -5793(96)0059 1- 1 
230 P~ Wiesner et al./FEBS Letters 389 (1996) 229-232 
150 
t- 
E3 
0 n- 
ft. 
100 
5o 
(d) 
1.5 
1 
0.5 
0 
d(product)/dt [~M/s] 
(a) 
(a) 
i . . . . . . . . . .  , 
O O 0 
O O 
0 } u f ~  ~ I I 
0 1 O0 200 300 400 
TIME (sec.) 
Fig. 1. Impact of NO on the kinetic lag phase of linoleic acid oxygenation. Pure rabbit reticulocyte 15-1ipoxygenase (26 pmol) was incubated 
for various time periods in the absence and presence of NO (150 nmol) under anaerobic conditions; incubation volume, 100 p.1. Afterwards, 0.9 
ml of aerobic phosphate buffer containing 250 gM linoleic acid and 0.2% sodium cholate were added and the lipoxygenase activity was meas- 
ured spectrophotometrically. (a) 5 s pre-incubation without NO (control), (b) 5 s pre-incubation with NO, (c) 60 s pre-incubation with NO, (d) 
120 s pre-incubation with NO. Inset: First derivatives of the progress curves. 
zyme. These data suggest hat nitric oxide may reversibly 
interact with the rabbit 15-1ipoxygenases and convert it to 
an enzyme species which is less susceptible to peroxide activa- 
tion. A similar kinetic behaviour has been reported before for 
the soybean lipoxygenase-1 [6,8]. Furthermore, we found that 
the length of the lag period did depend on the NO concentra- 
tion (not shown). Quite unexpectedly, we observed a short- 
ening of the lag phase for longer pre-incubation periods 
(Fig. 1). 
3.2. Spectroscopic studies 
The mechanistic reasons for the appearance of the kinetic 
lag phase during short-term interaction of the lipoxygenase 
with NO may involve the formation of a dissociable complex 
between the ferrous lipoxygenase and NO. In order to obtain 
direct evidence for such a complex, EPR studies were carried 
out. The EPR spectrum of the native rabbit 15-1ipoxygenase 
(Fig. 2A, trace a) is characterised by a weak signal at g' = 4.3 
and a stronger one in the region of 2 < g' < 2.5. These signals 
were consistently observed with various enzyme preparations 
(n = 4). The signal at g '= 4.3 which may be due to the pres- 
ence of ferric iron co-ordinated in the 15-1ipoxygenase mole- 
cule was strongly augmented when the enzyme was treated 
with hydroperoxy linoleic acid (not shown). The structural 
reasons for the signal in the 2 < g '< 2.5 region are unclear. 
When the 15-1ipoxygenase was reacted with NO for a short 
time period (Fig. 2A, trace b) a strong signal at g '= 4.1 was 
detected. By computer simulation this signal was assigned to a 
ferrous iron-NO complex with a spin state s' of 3/2 and a zero 
field splitting D of about 15 cm -1. 
The time-dependent shortening of the kinetic lag phase 
(Fig. 1) suggested that nitric oxide may convert he lipoxygen- 
ase to an enzyme species which is more susceptible to peroxide 
activation. Activation of lipoxygenases by hydroperoxy fatty 
acids is a two-step process involving the oxidation of the 
ferrous lipoxygenase and the subsequent formation of a pur- 
ple-coloured ferric lipoxygenase-hydroperoxide complex 
[15,16]. If oxidation of the ferrous lipoxygenase were to take 
place during the lipoxygenase-NO interaction, the time-de- 
pendent shortening of the kinetic lag phase would become 
plausible. To test this hypothesis, the 15-1ipoxygenase was 
incubated with NO for 15 min and its EPR spectrum was 
taken. The spectrum of the control sample (Fig. 2B, trace c) 
which was not treated with nitric oxide but was taken through 
the same experimental protocol showed a weak signal at 
g= 4.3 indicating that a small percentage of the enzyme was 
present in its ferric form. Moreover, a signal of unknown 
structural origin at g' = 1.98 was observed. NO treatment re- 
suited in an EPR spectrum (Fig. 2B, trace d) which was char- 
acterised by at least 4 different paramagnetic species: (i) axial 
ferric species contributing to the signals at g' = 6.03 and 2.00; 
(ii) rhombically distorted ferric species with contribution to 
the signals at g' = 10.43, 4.30 and 2.00; (iii) less rhombically 
distorted and/or coupled ferric species with contributions to 
the signal at g'= 3.03; and (iv) unknown oxygen radicals 
which may give rise to the signal at g '= 1.98. These data 
R. Wiesner et aLIFEBS Letters 389 (1996) 229-232 231 
A 
g' = 4.3 
g '=4.0 
0 
J 
B g' = 1.98 
g' = 4.30 
g' = 3.03 
X2  
g' = 4.30 
0,= 1 6? / A g'= 2.00 
Fig. 2. EPR spectra of the rabbit 15-1ipoxygenase after its interaction with NO. (A) Native rabbit 15-1ipoxygenase (10 mg) was lyophilised 
from a volatile NH4HCO3 buffer (pH 7.6), packed into a 3 mm quartz tube and was flushed extensively with argon to remove oxygen. After 
taking the EPR spectrum at 4 K (trace a), nitric oxide gas was blown into the tube and the EPR spectrum was taken again (trace b). The sig- 
nal of an internal standard is marked by a circle. (B) To 1 ml of a partially anaerobised 15-1ipoxygenase solution (10 mg/ml) 2.0 ml of the ni- 
tric oxide stock solution (3 mM) were added. After 15 min of incubation the sample was frozen in liquid nitrogen, lyophilised and the EPR 
spectrum was taken at 4 K (trace d). In the control experiments (trace c) the enzyme was treated in the same way with the exception that a sa- 
turated argon solution was added instead of the NO stock. Note that the sensitivity of the control trace was twice that of the NO-treated sam- 
ple. 
suggest that nitric oxide treatment of mammalian lipoxy- 
genases may lead to oxidation of the ferrous enzyme species. 
Independent evidence for such oxidation was provided by 
X-ray absorption spectroscopy in the iron near edge region 
(XANES). It can be seen from Fig. 3 that the edge position 
for the native lipoxygenase was found at 7120.5 eV, a value 
characteristic for ferrous ions. A similar spectrum has been 
reported recently for this enzyme [17,18] and for the soybean 
lipoxygenase [18,19]. However, after treatment with nitric 
oxide the edge position was shifted to 7123.5 eV indicating 
the presence of ferric ions. 
4. Discussion 
Both NO [2,20] and lipoxygenase products such as leuko- 
trienes and hydroxy fatty acids [21-23] are messenger mole- 
cules which exhibit a variety of biologically relevant proper- 
ties. So far no direct interaction of both pathways in 
mammalian cells has been described. The data presented 
here indicate that nitric oxide is capable of interacting with 
a mammalian lipoxygenase and thus, may be regarded as a 
physiological modulator of the cellular lipoxygenase path- 
ways. Earlier studies on the soybean lipoxygenase charac- 
terised NO as reversible inhibitor of plant lipoxygenases 
[8,9]. The data presented here indicate that a mammalian lip- 
oxygenase is also inhibited when co-incubated for a short time 
period with NO. In addition and quite unexpectedly, we 
found that NO is capable of oxidising the enzyme-bound fer- 
rous non-heme iron when incubated with the lipoxygenase for 
longer time periods. This oxidation may be regarded as pre- 
activation of the enzyme and is reflected by a shortening of 
the kinetic lag phase. These data suggest hat NO may act as 
reversible inhibitor as well as activator of mammalian lip- 
oxygenases depending on the duration of their interaction. 
Although the mechanism of the NO-induced oxidation of 
the rabbit reticulocyte 15-1ipoxygenase has not been studied in 
detail, it may proceed in a similar way to NO-induced methe- 
moglobin formation [24]. Under our experimental conditions, 
the oxidation took place in the anaerobic pre-incubation mix- 
ture in which only the lipoxygenase and NO were present. 
Thus, an indirect effect of nitric oxide derivatives, such as 
peroxynitrile, appears unlikely. It should, however, be stressed 
that despite our efforts to exclude oxygen from the pre-incu- 
bation mixture to prevent massive NO autoxidation, complete 
anaerobiosis was certainly not achieved. Thus, NO-autoxida- 
tion intermediates may be involved in NO-induced lipoxygen- 
ase oxidation. In additional experiments, we excluded the pos- 
sibility that the oxidation of the lipoxygenase is a 
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Fig. 3. X-ray absorption spectra in the near edge region of the rab- 
bit 15-1ipoxygenase. The preparation of the lipoxygenase samples 
was carried out as described in the legend to Fig. 2. XANES spec- 
tra were taken as described in Section 2. Solid line, native lipoxy- 
genase (no NO treatment); dotted line, NO treated lipoxygenase. 
lyophilisation artefact. When the lyophilised ferrous lipoxy- 
genase was flushed with nitric oxide gas for 1 h and X-ray 
absorption spectra were taken subsequently a shift in the iron 
edge was observed, indicating that the oxidation the enzyme- 
bound iron proceeds during lipoxygenase-NO interaction. 
At this time it remains to be investigated whether the effects 
reported here are of cell physiological relevance. Preliminary 
kinetic studies on the lipoxygenase-nitric oxide interaction in- 
dicated a Kd for the formation of the lipoxygenase-NO com- 
plex of about 2.5 gM. Although no reliable data on intracel- 
lular NO concentrations are available, measurements of its 
extracellular steady-state concentration suggest [2,25] that 
gM concentration may well be reached at the site of NO 
synthesis. 
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